![Thomas J. Stegmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas J. Stegmann
Directeur/Membre du Conseil chez Flughafen Dortmund GmbH
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Grant Gordon | M | 62 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 26 ans |
Guntram Pehlke | M | 64 |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Hubert Jung | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Manfred J. Sauer | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Rüdiger Schmidt | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Friedrich Wilhelm Weber | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Frank Stewen | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Bianka Mark | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Ralf Exner | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Ludger van Bebber | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Benjamin Beckmann | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Cüneyt Karadas | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Sonja Lemke | F | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Heike Marzen | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Stefan Schreiber | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Oliver Stieglitz | M | - |
Flughafen Dortmund GmbH
![]() Flughafen Dortmund GmbH AirlinesTransportation Flughafen Dortmund GmbH is an airport located in Dortmund, Germany that offers affordable flights and parking options. The airport provides easy access to various destinations with short distances and low prices. The German company was founded in 1926 and is currently led by CEO Ludger van Bebber. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Daniel C. Montano | M | 75 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 16 ans |
John William Jacobs | M | 74 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 14 ans |
Mickael Flaa | M | 71 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 16 ans |
Gary Abromovitz | M | 81 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 7 ans |
Alexander Gene Montano | M | - |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | - |
Joong-Ki Baik | M | 69 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 9 ans |
Thomas L. Ingram | M | 69 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | - |
Robert Levin | M | 92 |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | - |
Mike Norris | M | - |
Venturis Therapeutics, Inc.
![]() Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Allemagne | 15 | 60,00% |
Etats-Unis | 10 | 40,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Thomas J. Stegmann
- Réseau Personnel